Departments of Pediatrics.
Pediatric Hematology/Oncology.
J Pediatr Hematol Oncol. 2024 Aug 1;46(6):e387-e392. doi: 10.1097/MPH.0000000000002910. Epub 2024 Jun 24.
Renal cancer, although still rare among individuals under 45 years of age, is on the rise in the general population. The risk and timing of subsequent renal cancer in survivors of childhood cancer is not well established. Using the SEER registry, we reported the incidence of subsequent malignant renal neoplasms after treatment for primary malignancy diagnosed under 20 years of age. We evaluated clinical characteristics, standardized incidence ratio (SIR), and Kaplan-Meier survival estimates. Fifty-three survivors developed subsequent renal cancer (54 total cases). Of these, 54.7% were female, 88.7% were white, and 13.2% were Hispanic. Mean ages at primary malignancy and subsequent renal cancer were 10.1 and 31.1 years, respectively. Forty-seven cases were second cancers, 6 were third, and 1 was fourth. For survivors of childhood cancer, the overall SIR for renal cancer was 4.52 (95% CI: 3.39-5.89). The 5-year overall survival rate after development of subsequent renal cancer was 73% (95% CI: 58%-83%). Renal cancer occurs 4.5 times more frequently in childhood cancer survivors than in the general population, necessitating long-term care considerations.
虽然在 45 岁以下的人群中肾癌仍然较为罕见,但在普通人群中肾癌的发病率正在上升。儿童癌症幸存者发生后续肾癌的风险和时间尚不清楚。我们使用 SEER 登记处报告了 20 岁以下诊断的原发性恶性肿瘤治疗后发生后续恶性肾肿瘤的发病率。我们评估了临床特征、标准化发病比 (SIR) 和 Kaplan-Meier 生存估计。53 名幸存者发生了后续肾癌(54 例)。其中,54.7%为女性,88.7%为白人,13.2%为西班牙裔。原发性恶性肿瘤和随后发生的肾癌的平均年龄分别为 10.1 岁和 31.1 岁。47 例为第二原发癌,6 例为第三原发癌,1 例为第四原发癌。对于儿童癌症幸存者,肾癌的总体 SIR 为 4.52(95%CI:3.39-5.89)。随后发生肾癌后的 5 年总生存率为 73%(95%CI:58%-83%)。儿童癌症幸存者发生肾癌的频率比普通人群高 4.5 倍,需要长期护理考虑。